This site is intended for health professionals only

COVID-19 vaccination reduces infection-related risk of myocardial infarction and stroke

COVID-19 vaccination reduces the risk of an acute myocardial infarction and ischaemic stroke among individuals infected with the virus according to the findings of a study by Korean researchers.

It is increasing recognised that an acute infection with COVID-19 leads to an increased risk of cardiovascular disease and which includes cerebrovascular disorders, dysrhythmias, ischaemic and non-ischaemic heart disease, pericarditis, myocarditis, heart failure and thromboembolic disease. Although there is very good evidence that a COVID-19 vaccination is safe and offers protection against severe COVID-19, hospitalisation and death against all current variants of concern, it is uncertain whether vaccination also reduces the post-infection cardiovascular sequelae. Consequently, in the present study, the Korean researchers performed a retrospective cohort study to compare the incidence of acute myocardial infarction and ischaemic stroke in those with and without full COVID-19 vaccination. Linking the Korean nationwide COVID-19 registry and the National Health Insurance database, the team included all adults diagnosed with COVID-19 between July 2020 and December 2021, although researchers excluded several patient groups including: individuals whose data showed that they had a cardiovascular event three months before a COVID-19 infection; cases of re-infection with the virus; and patients who were vaccinated but hospitalised with the virus for longer than 30 days. The primary outcome of interest was a composite of all hospitalisations for an acute myocardial infarction and ischaemic stroke and which had occurred 31 to 120 days after an individual’s COVID-19 diagnosis. They decided to exclude cardiovascular events within the first 30 days of infection because of the inherent difficulty of differentiating whether the event was related to infection of treatment.

COVID-19 vaccination and cardiovascular outcomes

A total of 231,037 patients were included in the analysis, of whom, 62,727 were unvaccinated with a median age of 42 years (51.5% female). The median age of the vaccinated group was higher (57 years) and individuals had a greater incidence of co-morbidities including diabetes (11.8% vs 7.1%, vaccinated vs unvaccinated) and hypertension (22.1% vs 10.8%). Furthermore, a higher proportion of unvaccinated individuals had severe COVID-19 (3.1% vs 9.8%). The median period of follow-up was 90 days in the unvaccinated and 84 days in the fully vaccinated group (which was defined as receipt of two doses of a vaccine).

The composite outcome occurred in 31 unvaccinated individuals and 74 of those who were fully vaccinated and after adjustment for differences in baseline characteristics, this difference was statistically significant (hazard ratio, HR = 0.42, 95% CI -.29 – 0.62, p < 0.001). This difference was also significant for the individual components of the composite.

The authors concluded that full COVID-19 vaccination was protective against the acute myocardial infarction and ischaemic strokes that can arise due to an infection with the virus, compared to individuals who were unvaccinated.

Kim YE et al. Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection JAMA 2022

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine